Trial Details

RECRUITING
Basic Information
Clinical ID c1324
Identifier NCT06663605
Trial Title Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients.
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis (UC)|Healthy Volunteer
Interventions DRUG: PALI-2108|DRUG: PALI-2108 Placebo
Participant Information
Sponsor Palisade Bio
City Montreal
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2024-11-05
Primary Completion Date 2025-04-24
Completion Date 2025-07-01